Aromatherapy Inhaler Use for HSCT Distress

Recruiting now · Not applicable

Conditions studied: Cancer Distress, Cancer Coping, Hematopoetic Stem Cell Transplant, Aromatherapy

In brief

This randomized controlled trial will evaluate the feasibility and acceptability of an inhaled aromatherapy stick for patients during the acute inpatient phase after hematopoietic cell transplantation (HCT) . The study will also explore whether aromatherapy use is associated with short-term changes in patient-reported cancer-related distress and coping self-efficacy.

Key facts

Study ID
NCT05302583
Run by
Stanford University
People needed
50
Starts
2025-06-16
Expected to finish
2026-06-01
Last updated by the study team
2026-06-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.